SCHEMBL1492708

SCHEMBL1492708

Cc1[c]c2cc(Cl)ccc2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
HPGD P15428 2/20 0.41
GAA P10253 2/20 0.41
CYP1A2 P05177 1/20 0.41
ALDH1A1 P00352 3/20 0.39
PSMB8 P28062 3/20 0.39
POLB P06746 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HAVCR2 Q8TDQ0 1/20 0.39
HSD17B10 Q99714 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17423816 0.86 ALDH1A1 (0.44) LMNAHPGDGAACYP1A2ALDH1A1
SCHEMBL2071518 0.79 CA12 (0.38) HPGDGAAALDH1A1PSMB8POLB
SCHEMBL6015758 0.76 CYP2A6 (0.46) HPGDGAAALDH1A1PSMB8POLB
SCHEMBL2073232 0.76 GAA (0.38) HPGDGAACYP1A2ALDH1A1POLB
SCHEMBL2072959 0.73 KIF11 (0.43) HPGDGAAALDH1A1ALOX15TSHR
SCHEMBL2071613 0.73 KIF11 (0.40) HPGDGAACYP1A2ALDH1A1SMN1; SMN2
SCHEMBL2074318 0.73 KDM4E (0.50) HPGDALDH1A1PSMB8TSHRHSD17B10
SCHEMBL29547 0.70 AHR (0.37) LMNAHPGDGAACYP1A2ALDH1A1
SCHEMBL2072913 0.69 GRIA1 (0.49) LMNAGAAALDH1A1POLBTSHR
SCHEMBL11030089 0.65 TP53 (0.43) LMNAHPGDALDH1A1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators AMGEN INC. 2011-05-19 US disclosed
EP-2300427-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2011-03-30 EP disclosed
WO-2009137404-A1 UREA COMPOUNDS AS GAMMA SECRETASE MODULATORS AMGEN INC. (US) 2009-11-12 WO disclosed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 EP disclosed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 WO disclosed
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110118234-A1 Urea Compounds as Gamma Secretase Modulators BACE1, BACE2, PSEN1 LMNA 1262/4885HPGD 1042/4885GAA 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.